# Lacosamide Versus Propranolol in Migraine

> **NCT05851781** · PHASE3 · COMPLETED · sponsor: **Kafrelsheikh University** · enrollment: 600 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Lacosamide tablet
- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT05851781
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2024-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05851781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05851781, "Lacosamide Versus Propranolol in Migraine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05851781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*